ADVERTISEMENT

To Take or Not to Take

Role of antioxidants called into question -- again. 

BY LENA HUANG
PUBLISHED MONDAY, SEPTEMBER 8, 2008
Talk about this article with other patients, caregivers, and advocates in the General Discussions CURE discussion group.
Scientists have long investigated the connection between antioxidants and cancer, and now a new study reported in the Journal of the National Cancer Institute concludes that cancer patients undergoing radiation or chemotherapy should avoid routine use of antioxidant supplements. 

With about 60 percent of cancer patients reporting that they take some type of vitamin supplement, according to the American Cancer Society, the relationship between antioxidants and cancer begs for clarity.

The debate is complex because a variety of antioxidants exists, not only in food and in supplements but also manufactured by the body. Combine that with the number of cancer therapies, cancer stages, tumor types, and other variables, and it is no wonder there are varying opinions on the topic.

For the JNCI study, researchers combed through two decades of clinical trials that had concurrent administration of antioxidant supplements with chemotherapy or radiation. They found three randomized studies focused on radiation and 16 on chemotherapy. While some of these studies showed antioxidant benefits, such as a reduction in side effects, others showed a decrease in survival rates of cancer patients.

With these varying assumptions, Brian D. Lawenda, MD, lead investigator of the study, said his team based their conclusion on the physician’s dictum of “first, do no harm,” that in the absence of beneficial evidence, doctors should advise against the use of high-dose supplemental antioxidants during radiation and chemotherapy until further studies are done.

Antioxidants are substances that block oxidation and affect many processes. One role they have is protecting cells from free radical damage. Free radicals (highly reactive molecules produced during normal metabolism and by environmental toxins) damage DNA, a reaction that may cause certain genes (the parts of DNA that encode proteins) to develop mutations, which can initiate new cancer cells or promote the growth of existing ones.

Many chemotherapy agents and radiation therapies work by inducing free radicals that damage cancer cell DNA and proteins. And while this can harm normal cells, it causes even more damage to rapidly growing cancer cells. So taking large doses of antioxidant supplements may interfere with these therapies by reducing their anticancer activity, according to Lawenda’s study.

However, Lawenda, who is also the clinical director of radiation oncology at Naval Medical Center San Diego, adds that patients should not interpret this conclusion to mean they should remove foods with antioxidants from their diets. “Importantly, the potential adverse consequences of antioxidant supplements may be related to the high doses in which they are administered—intakes which cannot be easily achieved by any diet rich in these plant foods.”

Some commonly known natural antioxidants are vitamin C, which is found in citrus fruits and blueberries, and beta-carotene, which is found in carrots and other orange foods. These antioxidants and others have been studied in large-scale clinical trials since the 1980s with some showing promise and others revealing increases in cancer rates.

More recent research derived from cell culture and animal studies suggests antioxidants may slow or prevent cancer. “There are numerous reports that chemopreventive agents derived from natural sources—fruits, vegetables, spices—have antioxidant activity and are beneficial,” says Bharat B. Aggarwal, PhD, professor of experimental therapeutics at M.D. Anderson Cancer Center in Houston.

Aggarwal has studied numerous agents in fruits and vegetables, such as curcumin (a spice), lycopene (found in tomatoes), and resveratrol (found in grapes), that target specific molecular actions that can have preventive effects on cancer and other diseases.

Until further studies on specific antioxidants and cancer outcomes are done, Lawenda recommends patients get a natural mix of antioxidants through food sources as specified through the federal government’s dietary guidelines (www.health.gov/dietaryguidelines).

“We recommend that patients continue to meet the established dietary requirements [set by the government] for the essential vitamins C and E and the intake of carotenoids, flavonoids, and related antioxidant phytochemicals,” Lawenda says.

Talk about this article with other patients, caregivers, and advocates in the General Discussions CURE discussion group.
ADVERTISEMENT
ShareYourStory
Related Articles
Seeing Red
BY MICHAEL A. POSTOW
Rash is the most common side effect of cancer immunotherapies, but patients should watch for more serious issues.
Chemo Use Does Not Improve Quality of Life Near Death
BY ANDREW J. ROTH
Though many patients with cancer are offered chemotherapy as palliative care during end-of-life treatment, its benefit has not been well studied previously.
Breast Reduction or Mastectomy: Yoga and Cancer
BY JEAN DI CARLO-WAGNER
There was only one problem. I had scheduled a breast reduction surgery with a private plastic surgeon. The accidental overlap of drawing blood for genetic testing, and my surgery date made, me stop and think. Would I do anything differently?
Zyprexa Relieves Nausea in Patients Treated for Head and Neck Cancer
BY LAURA MARTIN
Nausea and vomiting associated with anticancer therapies continue to be among patients’ most troubling symptoms.
IV Emend Helps Prevent CINV With Moderately Emetogenic Chemotherapy
BY LAUREN M. GREEN
A single intravenous dose of EMEND for Injection was shown to be superior to placebo when either were combined with other anti-vomiting agents for protection against CINV in patients receiving moderately emetogenic chemotherapy.
Related Videos
Cokie Roberts on Addressing the Whole Person During Treatment
BY COKIE ROBERTS
Cokie Roberts, a journalist, discusses the importance of addressing the whole person during treatment.
Patrick I. Borgen on Cancer-Related Pain Relief With Exparel
BY PATRICK I. BORGEN
Patrick I. Borgen, chair, Department of Surgery, director, Maimonides Breast Cancer Center, provides an overview of cancer-related pain relief with Exparel.
Patrick I. Borgen Discusses Opioids for Treating Cancer-Related Pain
BY PATRICK I. BORGEN
Patrick I. Borgen, chair, Department of Surgery, director, Maimonides Breast Cancer Center, comments on opioid use for cancer-related pain.
Rep. Frank Pallone Jr. on Streamlining the Anti-Cancer Drug Approval Process
BY REP. FRANK PALLONE JR.
Rep. Frank Pallone Jr., Sixth Congressional District of New Jersey, House Energy and Commerce Committee, discusses “streamlining” the FDA’s drug approval process as it relates to the 21st Century Cures Act.
Anya Prince on Insurance Coverage for Preventative Services
BY ANYA PRINCE
Anya Prince, a post-doctoral fellow at the Center for Genomics and Society at The University of North Carolina at Chapel Hill, discusses insurance coverage for preventative services.
$auto_registration$
VSEO N/A